Lower riskDrug recall · FDA · Published September 22, 2023
West-Ward Methotrexate Tablets Recall: Unsmooth Surface and Illegible Labels
West-Ward recalls 2.5 mg methotrexate tablets with unsmooth surfaces and illegible labels. These tablets may not be properly identified or scored, posing risks for patients using prescription medication.
Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.
Take action
Contact the company
📍Recalling firmWest-Ward Columbus Inc1809 Wilson Rd · Columbus, OH 43228-9579
“West-Ward Methotrexate Tablets Recall: Unsmooth Surface and Illegible Labels.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33095-west-ward-methotrexate-tablets-recall-unsmooth-surface-and-illegible-labels. Based on FDA recall #D-0066-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0066-2024%22&limit=1).
The FDA announced on Sept. 22, 2023, that West-Ward Columbus Inc is recalling Methotrexate Tablets, USP, 2.5 mg due to failed tablet specifications. The agency stated the recall was voluntary and initiated by the firm.
According to the FDA, the tablets were observed to have an unsmooth surface. Two tablets demonstrated illegible tablet identification and scoring.
Context
GovInfoNow's records show West-Ward Columbus Inc has 8 other recalls on record since May 19, 2016. Recent similar recalls include a Dec. 19, 2024, recall of West-Ward Methadone Tablets for illegible product labels and a July 22, 2020, recall of Leucovorin Calcium Tablets due to labeling errors. Other recent recalls of similar products include an Aug. 19, 2026, American Health Packaging Buprenorphine Tablets recall for label mix-up hazard and a March 16, 2026, Meclizine 12.5mg Tablets recall for failed tablet specifications.
How to tell if you have this one
Check for the lot numbers AB7486B (exp Dec 2023), AB8766B (exp April 2024), or AB9484B (exp Aug 2024) on the packaging. The product is a 2.5 mg methotrexate tablet, 10x10 unit-dose per carton, prescribed only.
Brand
West-Ward
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for lot numbers AB7486B (exp Dec 2023), AB8766B (exp April 2024), or AB9484B (exp Aug 2024) on the packaging.
Where it went and when
Where it was distributed
Distributed in Mississippi and Ohio.
Listed by the agency
Not listed
FDA distribution: “MS, OH” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Mississippi, Ohio.
Recall timeline
FDA published this recall 40 days after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0066-2024 (September 22, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0066-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.